½ÃÀ庸°í¼­
»óǰÄÚµå
1560798

¼¼°èÀÇ ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå(2024-2031³â)

Global Humanoid Robots in Healthcare Market - 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ °³¿ä

¼¼°èÀÇ ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 5¾ï 8,650¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 63¾ï 745¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ 2024³âºÎÅÍ 2031³â±îÁö CAGRÀº 34.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº Àΰ£°ú °°Àº Ȱµ¿°ú »óÈ£ÀÛ¿ëÀ» ¸ð¹æÇϱâ À§ÇØ ¸¸µé¾îÁø ÀΰøÀûÀÎ Àΰ£°ú °°Àº ±â°èÀÔ´Ï´Ù. Á¦Á¶, â°í°ü¸® ¹× ¹°·ù, °Ç¼³, Á¢°´ ¹× ¿£ÅÍÅ×ÀÎ¸ÕÆ®, ÇコÄɾî, ÀÏ¹Ý ¼­ºñ½º µîÀÇ ºÐ¾ß¿¡ ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ·Îº¿Àº ÇöÀç °Ç°­ °ü¸® »ê¾÷¿¡¼­ °í·ÉÀÚ °£È£ÀÇ µ¿¹ÝÀڷμ­ ÀÔ¿ø ȯÀÚ¿Í ÀçÅà ȯÀÚÀÇ »ýü ¸Å°³ º¯¼ö¸¦ ±â·ÏÇÏ°í ¸ð´ÏÅ͸µÇÏ°í º´¿ø ³»¿¡¼­ ÀϹÝÀûÀΠȰµ¿À» Áö¿øÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÃËÁø¿äÀÎ

·Îº¿ °øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡

ÇöÀçÀÇ ¼¼°è¿¡¼­ ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº Àΰ£Ã³·³ ±â´ÉÇÏ°í »ý°¢ÇÏ´Â ´É·ÂÀ» °®±â ¶§¹®¿¡ Å« Àα⸦ ¸ðÀ¸°í ÀÖ´Â ÃÖ÷´Ü ·Îº¿ÀÔ´Ï´Ù. ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº Á¦Á¶¾÷, â°í °ü¸® ¹× ¹°·ù, Á¢°´, ¿£ÅÍÅ×ÀÎ¸ÕÆ® µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÀÌ¹Ì µµÀԵǰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ¾÷°è¿¡¼­´Â ÀÌ·¯ÇÑ ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ ¿ëµµ´Â ¾ÆÁ÷ ¹ß°ßµÇÁö ¾Ê¾ÒÀ¸¸ç, ·Îº¿À» »óǰȭÇϰí ÀÖ´Â ±â¾÷Àº ÇÑÁ¤µÇ¾î ÀÖ½À´Ï´Ù. ±×·¯³ª ÇコÄɾî´Â ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ ¹Ì·¡¿¡ °¡Àå À¯¸ÁÇÑ ºÐ¾ßÀ̸ç, ÈÞ¸Ó³ëÀÌµå ·Îº¿À» °³¹ß ¹× µµÀÔÇϱâ À§ÇØ Á¦Á¶¾÷ü³ª Á¤ºÎ·ÎºÎÅÍ ÅõÀÚ¿Í ÀÚ±Ý Áö¿øÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀÚ ¹× ÀÚ±Ý Á¶´ÞÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÌ µÇ¾ú½À´Ï´Ù.

¿¹¸¦ µé¾î 2023³â 11¿ù º£ÀÌ¡ Á¤ºÎÀÇ Áö¿øÀ¸·Î º£ÀÌ¡¿¡ »õ·Î¿î ÈÞ¸Ó³ëÀÌµå ·Îº¿ Çõ½Å ¼¾ÅͰ¡ ¼³¸³µÇ¾ú½À´Ï´Ù. ¼³¸³ ÈÄ 1³â À̳»¿¡ ÀÌ ¼¾ÅÍ´Â Tien KungÀ̶ó´Â »õ·Î¿î ÈÞ¸Ó³ëÀÌµå ·Îº¿À» Á¦Á¶Çß½À´Ï´Ù. ÈÞ¸Ó³ëÀÌµå ·Îº¿ Çõ½Å ¼¾ÅÍÀÇ ÃÑÃ¥ÀÓÀÚÀÎ Rick Xiong¾¾´Â ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº ÇâÈÄ 3-5³â ¾È¿¡ °¡Á¤¿¡¼­ º¸´Ù ´ë±Ô¸ð·Î ÀÀ¿ëµÉ °ÍÀ̶ó°í ¸»ÇÕ´Ï´Ù.

¶ÇÇÑ Çõ½Å ÁÖµµÇü ÈÞ¸Ó³ëÀÌµå ·Îº¿ °³¹ß ±â¾÷ÀÎ Sanctuary AI´Â 2024³â 7¿ù±îÁö ´Ù¾çÇÑ ÅõÀÚÀÚµé·ÎºÎÅÍ 1¾ï 4,000¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Á¶´ÞÇß½À´Ï´Ù. ÀÌ È¸»ç´Â 2022³â ÃÊ Ä³³ª´Ù Á¤ºÎ·ÎºÎÅÍ 3,000¸¸ ´Þ·¯ÀÇ Àü·«Àû Çõ½Å ±â±ÝÀ» ¹Þ¾Ò½À´Ï´Ù. Sanctuary AI´Â ÀÌ·¯ÇÑ ÀÚ±ÝÀ» Ȱ¿ëÇÏ¿© AI(ÀΰøÁö´É) ¹× ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ Çõ½ÅÀ» °¡¼ÓÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

Çõ½Å ´Ü°è¿¡ ÀÖÀ¸¸ç Á¤ºÎ¿Í ¹Î°£ ºÎ¹®¿¡¼­ ¸¹Àº ÀÚ±ÝÀ» ¹Þ°í ÀÖ´Â ¿©·¯ ȸ»ç°¡ ÀÖ½À´Ï´Ù. ÀÌ ÀÚ±ÝÀº ÷´Ü ÀÎÇü ·Îº¿ÀÇ °³¹ß¿¡ Ȱ¿ëµÇ¾î °Ç°­ °ü¸® ºÐ¾ßÀÇ ¹ßÀÚÃ븦 È®´ëÇÒ ¼öµµ ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ

ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀåÀº ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ °¡¿ë¼ºÀÌ Á¦ÇѵǾî ÀÖ°í, ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ ¿ëµµ°¡ Á¦ÇѵǾî ÀÖ°í, ºñ¿ëÀÌ ¸¹ÀÌ µå´Â µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ¾ïÁ¦µÇ°í ÀÖ½À´Ï´Ù. ÇöÀç, ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº ÁÖ·Î ³ëÀÎ °£È£ÀÇ µ¿¹ÝÀڷμ­ ȯÀÚÀÇ ¼¼ºÎ »çÇ×°ú »ýü ¸Å°³ º¯¼öÀÇ ¼öÁý, ÀϹÝÀûÀÎ º´¿ø Ȱµ¿ º¸Á¶ µîÀÇ ¿ëµµ°¡ ¹ß°ßµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¸ðÈ£ÇÔÀ¸·Î ÀÎÇÑ ³ëÀεéÀÇ ÀúÇ×Àº °£È£ ¼­ºñ½ºÀÇ ÀÌ¿ëÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¼¼°èÀÇ ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀåÀº ¿îµ¿ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° ¹× Áö¿ªº°·Î ¼¼ºÐÈ­µË´Ï´Ù.

¿ëµµº°·Î´Â ³ëÀÎ Äɾ ¼¼°è ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå Á¡À¯À²ÀÇ ¾à 54.3%¸¦ Â÷ÁöÇÕ´Ï´Ù.

ÈÞ¸Ó³ëÀÌµå ·Îº¿Àº ÇöÀç ÇコÄÉ¾î »ê¾÷¿¡¼­ ÁÖ·Î ³ëÀÎ Äɾ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °í·ÉÀÚÀÇ ÀÏ»ó»ýȰÀÇ Áö¿ø, µ¿Çà, Ä¿¹Â´ÏÄÉÀÌ¼Ç Áö¿ø, ¹ÙÀÌÅ» »çÀÎÀÇ ÃøÁ¤, ÀÇ»ç¿ÍÀÇ ¸éȸ ¿¹¾à µî¿¡ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ·Îº¿Àº ¸Å¿ì Áö´ÉÀûÀ̸ç Àΰ£ÀÇ °¨Á¤°ú Ç¥Á¤À» ÀÌÇØÇϰí Àΰ£Ã³·³ ¹ÝÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. °¡Á¤, °£º´ ½Ã¼³, º´¿ø µî¿¡¼­ ½ÅüÀûÀÎ °³Á¶, üÁ¶ÀÇ Áöµµ, °¨Á¤ÀÇ Àνİú ¹àÀº ȯ°æ ¸¸µé±â, ÀÎÁö ´É·Â Çâ»óÀ» À§ÇÑ ¹ÝÁÖ µîÀ» ÅëÇØ, °í·ÉÀÚ¿¡°Ô Àû±ØÀûÀ¸·Î °ü¿©ÇÕ´Ï´Ù.

¼ÒÇÁÆ®¹ðÅ©·Îº¸Æ½½º ±×·ìÀÌ °³¹ßÇÑ ÈÞ¸Ó³ëÀÌµå ·Îº¿ ¡¸Pepper¡¹³ª ÈÄÁö ¼ÒÇÁÆ®ÀÇ ¡¸PALRO¡¹µîÀº °í·ÉÀÚ °£º´¿¡ ´ëÇÑ ¿ëµµ°¡ ÁÖÀÔ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ·Îº¿Àº ³ëÀÎ ÄÉ¾î ¿ëµµ¿¡ ±¹ÇѵÇÁö ¾ÊÀ¸¸ç, ÇコÄÉ¾î »ê¾÷ÀÇ ´Ù¸¥ ¿ëµµ¸¦ À§ÇØ ¸ÂÃãÈ­Çϰí ÈÆ·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, Prombot, Moxi, aeo, Abi¿Í °°Àº ´Ù¸¥ ·Îº¿µµ º´¿ø¿¡¼­ÀÇ µµ¿òÀ̳ª »ýü ¸Å°³º¯¼ö ¸ð´ÏÅ͸µ¿¡ ±¹ÇѵÇÁö ¾ÊÀ¸¸ç, ´Ù¸¥ ÀÇ·á¿ëÀ¸·Î ÈÆ·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ½ÃÀå ºÐ¼®

¼¼°èÀÇ ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå¿¡¼­ ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È 23.7%¶ó´Â ÃÖ°íÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Áß±¹°ú ÀϺ»ÀÇ »ê¾÷°è ¹× ¿¬±¸±â°ü¿¡¼­ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇϱ⠶§¹®¿¡ ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå¿¡¼­ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡µéÀº »ê¾÷ ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ·Î Àß ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ÇöÀç ´Ù¾çÇÑ ¿ëµµ·Î ÀÇ·á »ê¾÷¿¡¼­ ÈÞ¸Ó³ëÀÌµå ·Îº¿À» °³¹ßÇϰí Àü°³ÇÏ´Â ±â¼úÀ» º¸À¯Çϰí ÀÖ½À´Ï´Ù. ÇöÀç ÇコÄɾî Àü¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ½ÃÀå ¸®´õ´Â ÀϺ»°ú Áß±¹ÀÔ´Ï´Ù. °¡Àå À¯¸íÇÑ ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÎ Pepper´Â ÀϺ»ÀÇ ¼ÒÇÁÆ®¹ðÅ©·Îº¸Æ½½º ±×·ì¿¡ ÀÇÇØ °³¹ßµÇ¾ú½À´Ï´Ù. ÆäÆÛ´Â ÇöÀç ÀϺ»ÀÇ °í·ÉÀÚ °£º´ ½Ã¼³¿¡¼­ Ȱ¾àÇϰí ÀÖ½À´Ï´Ù.

°Ô´Ù°¡ ±¹Á¦¹«¿ª±¹¿¡ µû¸£¸é 2021³â ÀϺ»Àº 1¸¸¸íÀÇ Àΰ£¿¡ ´ëÇØ 631´ëÀÇ ·Îº¿ÀÌ ÀÏÇϰí ÀÖÀ¸¸ç ¹Ì±¹Àº 1¸¸¸í´ç 274´ë¹Û¿¡ ¾ø½À´Ï´Ù. 2065³â±îÁö ÀϺ»ÀÇ ³ëµ¿ Àα¸´Â 40% °¨¼ÒÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖÀ¸¸ç, ÀÎÇü ·Îº¿ ¼ö¿ä°¡ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Áß±¹Àº ¶ÇÇÑ ÈÞ¸Ó³ëÀÌµå ·Îº¿ °³¹ßÀÇ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. ¿©·¯ ±â¾÷°ú ¿¬±¸½Ã¼³ÀÌ Àû±ØÀûÀ¸·Î °³¹ßÀ» À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. »óÇÏÀÌ¿¡ º»»ç¸¦ µÐ ±â¾÷ '´ÙÅ× ·Îº¸Æ½½º'´Â ÈÞ¸Ó³ëÀÌµå ·Îº¿ÀÇ °³¹ß°ú ¼¼°è Àü°³¿¡ Àû±ØÀûÀ¸·Î ÀÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ È¸»ç´Â 2017³âºÎÅÍ ·Îº¿À» »óǰȭÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÎÇü ·Îº¿ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ Áß ÇϳªÀÎ iUBTT´Â Áß±¹ ¹ß»óÀ¸·Î ±¹³»»Ó¸¸ ¾Æ´Ï¶ó Àü ¼¼°è¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ½À´Ï´Ù. Áß±¹¿¡´Â ÀÌ·¯ÇÑ ±â¾÷µéÀÌ º£ÀÌ¡À» Áß½ÉÀ¸·Î ¸î °¡Áö ÀÖÀ¸¸ç ·Îº¿ ºÐ¾ßÀÇ Çõ½ÅÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ·Îº¿ °øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • ÇコÄÉ¾î »ê¾÷¿¡ À־ ÀÚµ¿È­ÀÇ ÁøÀü
    • ¾ïÁ¦¿äÀÎ
      • ÇコÄɾî¿ë ÈÞ¸Ó³ëÀÌµå ·Îº¿ ¿ëµµÀÇ ÇÑÁ¤
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®
  • ¾ð¸ä ¿ä±¸
  • PESTEL ºÐ¼®
  • ƯÇ㠺м®
  • SWOT ºÐ¼®

Á¦6Àå ¿îµ¿ À¯Çüº°

  • 2Á· º¸Çà
  • ¹ÙÄû½Ä

Á¦7Àå ¿ëµµº°

  • ¹ÙÀÌÅ» ÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅ͸µ
  • ¿¹¾à ½ºÄÉÁÙ¸µ
  • ³ëÀÎ Äɾî
  • º´¿ø Áö¿ø
  • ±âŸ

Á¦8Àå ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • ÀÇ·á°è ´ëÇÐ
  • ÀçÅà °£º´
  • ±âŸ

Á¦9Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃȲ ¹× Á¡À¯À² ºÐ¼®
  • M&A ºÐ¼®

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • SoftBank Robotics America, Inc.
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À ¹× ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • Promobot
  • FUJISOFT Inc
  • Hanson Robotics Ltd.
  • Diligent Robotics Inc.
  • Aeolus
  • andromeda.
  • Asimov Robotics.
  • UBTECH ROBOTICS CORP LTD.
  • Dataa Robotics

Á¦12Àå ºÎ·Ï

AJY 24.10.08

Report Overview

The Global Humanoid Robots in Healthcare Market reached US$ 586.50 million in 2023 and is expected to reach US$ 6,307.45 million by 2031, growing at a CAGR of 34.5% during the forecast period 2024-2031.

Humanoid robots are artificial human-like machines built to mimic human-like activities and interactions. These are the most advanced forms of robots in the current world, finding their applications in manufacturing, warehousing & logistics, construction, hospitality & entertainment, healthcare, and general services. These advanced robots are currently utilized in the healthcare industry as companions in elderly care, for vital parameter recording and monitoring in hospitalized and home-based patients, and for assistance in general activities in the hospital.

Market Dynamics: Drivers

Rising investments in robotics

In the current world, humanoid robots are the most advanced robots that are gaining huge popularity due to their ability to function and think like humans. The humanoid robots have already been deployed in various industries such as manufacturing, warehousing & logistics, hospitality, and entertainment. In the healthcare industry, these humanoid robots are still finding their applications, and only a limited number of companies have commercialized their robots. However, healthcare is the most promising sector for the future of humanoid robots, and the investments and funding are rising from the manufacturers and governments to develop and deploy them. These investments and funding are primary contributing factors to the market growth in the forecast period.

For instance, in November 2023, a new Humanoid Robot Innovation Center was established in Beijing with the support of the Beijing government. Within a year of its establishment, the center has produced a new humanoid robot called Tien Kung. The general manager of Humanoid Robot Innovation Center, Mr. Rick Xiong has stated that humanoid robotics will be applied on a larger scale at home in the next three to five years.

In addition, Sanctuary AI, an innovation-driven humanoid robot development company has raised US$ 140 million in funding from various investors till July 2024. The company received a US$ 30 million strategic innovation fund from the Canadian government earlier in 2022. Sanctuary AI aims to utilize these funds to accelerate its innovation in AI (artificial intelligence) and humanoid robotics.

There are several companies which are at the innovation stage and are hugely receiving funding from government and private sectors. This funding will be utilized by them for the development of advanced humanoid robots, which may also expand their footprint in the healthcare sector.

Restraints

The market for humanoid robots in healthcare is restrained by several factors such as the limited availability of humanoid robots, limitations of humanoid robot applications, high cost, etc. At present the humanoid robots majorly find their application as a companion for elderly care, collecting patient details and vital parameters, and assisting in general hospital activities. Moreover, resistance by the elderly due to technological ambiguity may also restrain their utilization of their care services.

Market Segment Analysis

The global humanoid robots in healthcare market is segmented based on movement type, application, end users, and region.

Elderly care in the application segment accounted for approximately 54.3% of the global humanoid robots market share

Humanoid robots are currently used in the healthcare industry mainly for elderly care. They find their application in assisting them in day-to-day activities, providing companionship, helping them to communicate, measuring their vital signs, scheduling appointments with doctors, etc. These robots are highly intelligent and can understand human emotions, and expressions and respond like a human. They actively engage seniors in the home, care facilities, and hospitals through physical assistance, guiding them in exercises, recognizing their emotions and creating a cheerful environment, providing companionship in improving their cognitive ability, etc.

The popular humanoid robot "Pepper" developed by SoftBank Robotics Group, and "PALRO" by FUJISOFT Inc. majorly find their application in providing elderly care. However, these robots are not just limited to elderly care applications, they can also be customized and trained for other applications in the healthcare industry. Similarly, the other robots like Prombot, Moxi, aeo, and Abi are not limited to hospital assistance, and vital parameter monitoring, they can also be trained for other healthcare applications.

Market Geographical Analysis

Asia-Pacific in global humanoid robots in healthcare market is expected to grow with the highest CAGR of 23.7% in the forecast period

Asia-Pacific region is experiencing significant growth in the humanoid robots in the healthcare market due to higher research and development activities across industries, and research institutes especially in China and Japan. These countries are well known for their investments in industrial automation and currently have the technology to develop and deploy humanoid robots in the healthcare industry for various applications. At present the market leaders in humanoid robots dedicated to healthcare, arise from Japan and China. Pepper, which is the most famous humanoid robot was developed by a Japanese company SoftBank Robotics Group. Pepper is currently serving senior care facilities in Japan.

Moreover, according to the International Trade Administration, Japan has 631 working robots for every 10,000 humans, and the U.S. has only 274 robots per 10,000 humans in 2021. By 2065, the workforce in Japan is expected to decline by 40%, which projects a higher demand for humanoid robots.

China is also at the forefront of humanoid robot development. Several companies and research facilities are actively involved in the development. A Shangai-based company "Dataa Robotics" is actively involved in developing and deploying humanoid robots all across the world. The company has commercialized its robots since 2017. Moreover, one of the leading companies in the humanoid robotics market, i.e., UBTECH originated from China and has expanded business in the country and across the globe. There are several such companies in China, majorly located in Beijing, which are driving innovations in the robotics field.

Market Segmentation

By Movement Type

Bipedal

Wheeled

By Application

Vital Parameter Monitoring

Appointment Scheduling

Elderly Care

Hospital Assistance

Others

By End Users

Hospitals & Clinics

Medical Universities

Homecare

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major players in the humanoid robots in healthcare market include SoftBank Robotics America, Inc., Promobot, FUJISOFT Inc, Hanson Robotics Ltd., Diligent Robotics Inc., Aeolus, andromeda., Asimov Robotics., UBTECH ROBOTICS CORP LTD., and Dataa Robotics among others.

Why Purchase the Report?

To visualize the global humanoid robots in healthcare market segmentation based on movement type, application, end users, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of humanoid robots in the healthcare market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global humanoid robots in healthcare market report would provide approximately 62 tables, 54 figures, and 175 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Movement Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising investments in robotics
      • 4.1.1.2. Rising automation in the healthcare industry
    • 4.1.2. Restraints
      • 4.1.2.1. Limited applications of humanoid robots in healthcare
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs
  • 5.5. PESTEL Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis

6. By Movement Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 6.1.2. Market Attractiveness Index, By Movement Type
  • 6.2. Bipedal*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Wheeled

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Vital Parameter Monitoring*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Appointment Scheduling
  • 7.4. Elderly Care
  • 7.5. Hospital Assistance
  • 7.6. Others

8. By End Users

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 8.1.2. Market Attractiveness Index, By End Users
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Medical Universities
  • 8.4. Homecare
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
      • 9.3.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.2. Germany
      • 9.3.5.3. UK
      • 9.3.5.4. France
      • 9.3.5.5. Italy
      • 9.3.5.6. Spain
      • 9.3.5.7. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
      • 9.4.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.2. Brazil
      • 9.4.5.3. Argentina
      • 9.4.5.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
      • 9.5.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.2. China
      • 9.5.5.3. India
      • 9.5.5.4. Japan
      • 9.5.5.5. South Korea
      • 9.5.5.6. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. SoftBank Robotics America, Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Promobot
  • 11.3. FUJISOFT Inc
  • 11.4. Hanson Robotics Ltd.
  • 11.5. Diligent Robotics Inc.
  • 11.6. Aeolus
  • 11.7. andromeda.
  • 11.8. Asimov Robotics.
  • 11.9. UBTECH ROBOTICS CORP LTD.
  • 11.10. Dataa Robotics (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦